Xenetic Biosciences Inc (XBIO) — Cash Flow-to-Debt Ratio
Xenetic Biosciences Inc (XBIO) has a Cash Flow-to-Debt Ratio of -0.59x as of September 2025, meaning its operating cash flow of $-658.25K could theoretically repay -1% of its total liabilities ($1.11 Million) in one year. See XBIO financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xenetic Biosciences Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Xenetic Biosciences Inc across 13 annual periods. For the full cash flow conversion analysis, see Xenetic Biosciences Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Xenetic Biosciences Inc (2012–2024)
Year-by-year debt coverage analysis for Xenetic Biosciences Inc. Check Xenetic Biosciences Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.15x | $-2.82 Million | $894.26K | ▲ +38.0% |
| 2023 | -5.08x | $-4.11 Million | $809.59K | ▼ -17.4% |
| 2022 | -4.33x | $-4.65 Million | $1.07 Million | ▼ -29.9% |
| 2021 | -3.33x | $-4.74 Million | $1.42 Million | ▲ +24.7% |
| 2020 | -4.43x | $-4.27 Million | $963.97K | ▼ -199.8% |
| 2019 | -1.48x | $-6.40 Million | $4.33 Million | ▼ -3.2% |
| 2018 | -1.43x | $-6.46 Million | $4.52 Million | ▼ -565.5% |
| 2017 | 0.31x | $1.49 Million | $4.86 Million | ▲ +116.8% |
| 2016 | -1.83x | $-8.79 Million | $4.80 Million | ▼ -255.4% |
| 2015 | -0.51x | $-5.30 Million | $10.30 Million | ▲ +75.6% |
| 2014 | -2.11x | $-12.33 Million | $5.84 Million | ▼ -139.1% |
| 2013 | -0.88x | $-6.05 Million | $6.85 Million | ▲ +35.2% |
| 2012 | -1.36x | $-6.26 Million | $4.59 Million | — |